Basic Information
Basic information for C5orf64-214-16aa-2
Peptide Name C5orf64-214-16aa-2
Genome Position chr5:61757467-61757514[+]
Species Human
Peptide Sequence MLAEITVNCSGVEPPG
Peptide Length 16
Unique No (C5orf64-209-16aa,C5orf64-212-16aa,C5orf64-216-16aa-1,C5orf64-220-16aa-1,C5orf64-227-16aa,C5orf64-228-16aa)
Grand Average of Hydropathicity 0.4312
Relative Molecular Mass 1887.13
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000659478;C5orf64-214
Transcript Length 5535
Coding Ability 0.4506
DNA Sequence Corresponding to Peptide ATGTTAGCAGAAATAACAGTTAATTGTTCAGGTGTAGAACCCCCAGGG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :